FDA counters KV s premature warning against compounding early-labor prevention drug
KV pharmaceuticals recently won exclusive rights to the marketing of the pre-term labor prevention drug they’ve branded Makena. Priced at a whopping $1500 per shot, the therapy may cost up to $30,000 per pregnancy since it usually requires 20 weekly injections to prevent premature labor in patients who have a predisposition to or a history of going into premature labor.
